07/15/2025
6:36 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2025
3:46 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:47 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:49 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:50 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2025
3:51 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2025
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2025
4:00 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/28/2025
4:00 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
Get the Latest News and Ratings for IOVA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Iovance Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
04/28/2025
4:05 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
03/18/2025
7:30 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:05 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:05 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
7:06 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:32 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:32 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:33 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:30 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
7:31 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2025
4:15 PM | Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/12/2025
4:17 PM | Iovance Biotherapeutics (Issuer)
Kirby Daniel Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/10/2025
6:22 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2025
4:59 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:00 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
5:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
4:15 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/02/2024
4:25 PM | Iovance Biotherapeutics (Issuer)
Puri Raj K. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/21/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/12/2024
6:11 PM | Iovance Biotherapeutics (Subject)
Maynard Ryan D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
8:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/18/2024
7:38 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024
5:30 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:32 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
5:33 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer? (Ad) Something extraordinary is happening in Washington.
For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations.
I'm talking about a $150 trillion American asset that's scattered across all 50 states.
While the mainstream media focuses on political theater, this story is quietly developing behind closed doors. We recently interviewed Rickards to get the full story and understand how everyday Americans can pre |
09/05/2024
6:52 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:53 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:54 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
6:56 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:10 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2024
7:00 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
7:01 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free IOVA Stock Alerts